SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ___________________ Date of Report (Date of earliest event reported) May 1, 2001 BICO, INC. (Exact name of registrant as specified in its charter) Pennsylvania 0-10822 25-1229323 (State of other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification No.) 2275 Swallow Hill Road, Bldg. 2500, Pittsburgh, Pennsylvania 15220 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (412) 429-0673 _________________________________________________________ (Former name or former address, if changes since last report.) Item 1. Change in Control of Registrant. Not applicable. Item 2. Acquisition or Disposition of Assets. Not applicable. Item 3. Bankruptcy or Receivership. Not applicable. Item 4. Changes in Registrant's Certifying Accountant Not applicable. Item 5. Other Events. BICO, Inc. announced today in response to the recent drop in its stock price that no material adverse developments have occurred to cause such a decline. Item 6. Resignation of Registrant's Directors. Not Applicable Item 7. Financial Statement, Pro Forma Financial Information and Exhibits. (a) Financial Statements and Businesses Acquired - Not Applicable. (b) Pro Forma Financial Information - Not Applicable. (c) Exhibits - Press Release. SIGNATURES Pursuant to the requirement of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. BICO, INC. by /s/ Fred E. Cooper Fred E. Cooper, CEO DATED: May 1, 2001 BICO REPORTS NO ADVERSE DEVELOPMENTS Pittsburgh, PA - May 1, 2001 - BICO, Incorporated (OTCBB:BIKO) announced today in response to the recent drop in its stock price that no material adverse developments have occurred to cause such a decline. The company is in a solid financial position with all projects proceeding very well. Subsidiary Petrol Rem, Inc. recently announced a significant revenue increase. ViaCirQ, Inc., BICO's subsidiary, a leading developer of extracorporeal hyperthermia medical devices, continues its negotiations with top hospitals and clinics for orders of its Thermo-Chem-HT System and disposable ThermoChem-HT system packs, which are used by physicians as adjunctive therapy in the treatment of patients with advanced cancer of the abdomen. BICO, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products. FOR FURTHER INFORMATION, CONTACT: Investors Media Diane McQuaide Susan Taylor 1.412.429.0673 phone 1.412.429.0673 phone 1.412.279.9690 fax 1.412.279.5041 fax INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204 WEBSITE: www.bico.com